Physicians' Academy for Cardiovascular Education

Positive results with SGLT2 inhibitor in patients with diabetic kidney disease across all levels of eGFR

3' education - Apr. 17, 2019

Educational information

This video was recorded at the ISN World Congress of Nephrology in Melbourne, Australia, on April 15, 2019.


Prof Carol Pollock, MD, is a nephrologist and Professor of Medicine at the University of Sydney School of Medicine, Sydney, Australia


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Read our summary of the CREDENCE trial

Share this page with your colleagues and friends: